Edaravone (Radical Scavenger) versus Sodium Ozagrel (Antiplatelet Agent) in Acute Noncardioembolic Ischemic Stroke (EDO Trial)

Publisher： Karger

E-ISSN： 1421-9786|27|5|485-492

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.27, Iss.5, 2009-03, pp. : 485-492

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Factors Affecting the First Recurrence of Noncardioembolic Ischemic Stroke - A randomized trial

By Wu T.-H.   Chen T.H.-H.   Lee T.-K.  

Thrombosis Research, Vol. 97, Iss. 3, 2000-02 ,pp. : 95-103

Elsevier

Access to resources Recommend Favorite

Treatment with Clopidogrel Prior to Acute Non-Cardioembolic Ischemic Stroke Attenuates Stroke Severity

By  

Cerebrovascular Diseases, Vol. 41, Iss. 5-6, 2016-01 ,pp. : 226-232

Karger

Access to resources Recommend Favorite

Effect of a Novel Free Radical Scavenger, Edaravone (MCI-186), on Acute Brain Infarction

By  

Cerebrovascular Diseases, Vol. 15, Iss. 3, 2003-03 ,pp. : 222-229

Karger

Access to resources Recommend Favorite

Does Current Oral Antiplatelet Agent or Subtherapeutic Anticoagulation Use Have an Effect on Tissue-Plasminogen-Activator-Mediated Recanalization Rate in Patients with Acute Ischemic Stroke?

By  

Cerebrovascular Diseases, Vol. 30, Iss. 5, 2010-09 ,pp. : 508-513

Karger

Access to resources Recommend Favorite

Interest of Antiplatelet Drug Testing after an Acute Ischemic Stroke

By  

European Neurology, Vol. 74, Iss. 3-4, 2015-09 ,pp. : 135-139

Karger

Access to resources Recommend Favorite